ARKK Daily Position Changes Report - June 3, 2026
Overview
On June 3, 2026, the ARK Innovation ETF (ARKK) made several notable adjustments to its portfolio. The fund increased its positions in Tesla Inc and CRISPR Therapeutics AG while reducing its stakes in Advanced Micro Devices Inc and Robinhood Markets Inc-A. The overall trading activity reflects a strategic shift in focus towards companies that are perceived to have strong growth potential.
Detailed Summary
The daily position changes for ARKK reveal a mix of buying and selling activity across its holdings. Tesla Inc (TSLA) saw an increase in its portfolio weight, indicating a bullish outlook from ARK Invest. Conversely, Advanced Micro Devices Inc (AMD) experienced a decrease in its weight, suggesting a potential reevaluation of its growth prospects. Other significant moves included increases in CRISPR Therapeutics AG (CRSP) and Roku Inc (ROKU), while Shopify Inc (SHOP) and Beam Therapeutics Inc (BEAM) were trimmed. The changes reflect ARK's ongoing strategy to pivot towards companies that align with its innovation-focused investment philosophy.
Position Changes Summary
| Ticker | Company Name | Direction | Estimated Trade Value ($) | % of Portfolio Change |
|---|---|---|---|---|
| TSLA | Tesla Inc | Buy | 14,494,705.16 | 0.2825% |
| AMD | Advanced Micro Devices Inc | Sell | -34,584,139.74 | -0.5630% |
| CRSP | CRISPR Therapeutics AG | Buy | 10,593,639.84 | 0.1501% |
| TEM | Tempus AI Inc-A | Sell | -18,382,554.28 | -0.3054% |
| ROKU | Roku Inc-A | Buy | 13,336,832.93 | 0.1497% |
| HOOD | Robinhood Markets Inc-A | Sell | -26,534,467.45 | -0.3721% |
| CRCL | Buy | 10,611,148.72 | 0.2370% | |
| SHOP | Shopify Inc-A | Sell | -10,388,448.20 | -0.1257% |
| COIN | Coinbase Global Inc-A | Buy | 5,558,273.36 | 0.0939% |
| BEAM | Beam Therapeutics Inc | Sell | -9,852,877.26 | -0.1257% |
Analysis and Interpretation
The shifts in ARKK's holdings reflect a calculated approach to capitalize on emerging trends in technology and healthcare. The increase in Tesla's position aligns with the company's strong performance and innovation in electric vehicles and energy solutions. The reduction in AMD's weight may indicate concerns over market saturation or competitive pressures in the semiconductor industry. ARK's continued investment in CRISPR Therapeutics indicates confidence in the biotech sector's potential for groundbreaking advancements. Overall, these changes suggest a focus on maximizing growth opportunities while managing risks associated with market volatility.
This report will be updated weekly to provide ongoing insights into ARKK's trading strategies and market positioning.
Explore more exclusive insights at nextfin.ai.
